Community Outreach and Engagement at U.S. Cancer Centers: Notes from the Third Cancer Center Community Impact Forum
- PMID: 37791915
- PMCID: PMC11058538
- DOI: 10.1158/1055-9965.EPI-23-1017
Community Outreach and Engagement at U.S. Cancer Centers: Notes from the Third Cancer Center Community Impact Forum
Abstract
Community outreach and engagement (COE) is a fundamental activity of cancer centers as they aim to reduce cancer disparities in their geographic catchment areas. As part of COE, NCI-Designated Cancer Centers must monitor the burden of cancer in their catchment area, implement and evaluate evidence-based strategies, stimulate catchment area relevant research, support clinical trial enrollment, and participate in policy and advocacy initiatives, in addition to other responsibilities. The Cancer Center Community Impact Forum (CCCIF) is a national annual meeting of COE professionals who work at or with cancer centers across the country. CCCIF grew out of earlier discussions at American Society of Preventive Oncology (ASPO) annual meetings, where COE was often discussed, but not exclusively. The third annual CCCIF meeting-hosted by the Sidney Kimmel Cancer Center at Thomas Jefferson University-was held in June 2022 in Philadelphia, PA, where more than 200 participants listened to dynamic presentations across 12 COE-related panel sessions. CCCIF leadership and ASPO AD/PL Workshop Planners worked together on the agenda. The 12 sessions used a COE lens to focus on: Diversity, Equity, and Inclusion; Policy; State Cancer Coalitions; Evaluation and Metrics; Implementation Science; In-reach; Outreach; Training and Education; Funding, Personnel and Resources; Clinical Trials; Innovative Methods; and Lessons from the COVID-19 pandemic. This article is a summary of main points and key lessons from each session, as well as a summary of overarching themes that were evident across the sessions.
©2023 American Association for Cancer Research.
Conflict of interest statement
The authors declare no potential conflicts of interest.
Figures
References
-
- National Institutes of Health. Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional. Available at: https://grants.nih.gov/grants/guide/pa-files/PAR-21-321.html
-
- National Institutes of Health. Notice of NIH’s Interest in Diversity. Available at: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-031.html
-
- Centers for Disease Control and Prevention. National Comprehensive Cancer Control Program. Available at: https://www.cdc.gov/cancer/ncccp/index.htm
-
- Centers for Disease Control and Prevention. A framework for program evaluation. Available at: https://www.cdc.gov/evaluation/framework/index.htm
Publication types
MeSH terms
Grants and funding
- P30 CA077598/CA/NCI NIH HHS/United States
- P30 CA015704/CA/NCI NIH HHS/United States
- P30 CA014599/CA/NCI NIH HHS/United States
- P30 CA023108/CA/NCI NIH HHS/United States
- P30 CA076292/CA/NCI NIH HHS/United States
- P30 CA142543/CA/NCI NIH HHS/United States
- P30 CA021765/CA/NCI NIH HHS/United States
- P30 CA177558/CA/NCI NIH HHS/United States
- P30 CA016520/CA/NCI NIH HHS/United States
- P30 CA016058/CA/NCI NIH HHS/United States
- P30 CA042014/CA/NCI NIH HHS/United States
- P30 CA056036/CA/NCI NIH HHS/United States
- P30 CA124435/CA/NCI NIH HHS/United States
- P30 CA006927/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources